Home » News » Page 365

Category

News

Cash in on tax credits

Research and development (R&D) tax credits are a tax relief based on your company’s investment in innovative technology.

News

News

Matt Lovett has the Wow factor

Seventeen-year-old Matt Lovett started his business, WowVoucherCodes.com, from his bedroom while revising for his GSCEs. He was recently presented with an award by Alistair Darling.

News

2ergo buys AMT

2ergo Group Plc, a Salford-based provider of mobile phone marketing and technology, has acquired rival Activemedia Technologies (AMT) for an undisclosed sum. 

News

Iofina in US takeover

US-focused iodine and natural gas concern Iofina is set to buy versatile Kentucky-based speciality chemical maker H&S Chemicals.

News

Viking Moorings in secondary buy-out

Aberdeen-based Viking Moorings, which serves the offshore oil and gas industry, has been acquired by HSBC from Inflexion Private Equity.

News

Hi-media on a roll

As revenues plummet and budgets tighten, advertising is often one of the first areas to be sacrificed. That's not stopping Paris-based media and online advertising group Hi-media. 

News

Soup maker TSC in buy-out

TSC Foods, a UK manufacturer of chilled and frozen soups and sauces, has been sold for £24 million in a private equity-backed buy-out.

News

Babcock & Brown infrastructure arm sold off

News

Soup maker TSC in buy-out

TSC Foods, a UK manufacturer of chilled and frozen soups and sauces, has been sold for £24 million in a private equity-backed buy-out.

News

Babcock & Brown infrastructure arm sold off

News

Tracsis caught Peeping

Tracsis Plc, a Leeds-based provider of transport consultancy services, has acquired rival Peeping for an initial consideration of up to £260,000 in cash and shares. 

News

Private equity comeback?

The UK private equity deal drought has not ended, but there are rays of light, according to quarterly research by corporate finance advisory boutique Corbett Keeling.

News

PartyGaming buys Cashcade

PartyGaming has acquired local rival Cashcade for up to £95.9 million.

News

ImmuPharma sells shares

Drug discoverer ImmuPharma’s chairman and chief executive have sold £10.75 million of shares to M&G and other institutions.

Recommended Content